Home
Harbour BioMed

Harbour BioMed Market Share Analysis for August 2026

harbour biomed (hbm holdings) is a global biopharmaceutical company committed to the r&d and commercialization of novel antibody therapeutics in oncology and immunological diseases.

Health > Biotechnology and Pharmaceuticals

Domainharbourbiomed.com

Year Founded2016

Employees51 - 200

Annual Revenue$25M - $50M

Harbour BioMed

Harbour BioMed (including company regionals)

harbourbiomed.com

See more website traffic and engagement information

Harbour BioMed Revenue up to August 2026 is 25M - 50M

revenue generated by Harbour BioMed top domains

Harbour BioMed top domains revenue over 3 years

Revenue for Harbour BioMed top domains

harbourbiomed.com25M - 50M

See more with Sales Intelligence

Total visits to Harbour BioMed's top domains

Understand Harbour BioMed market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

harbourbiomed.com4.8K

See more with Sales Intelligence

Avg. visit duration in Harbour BioMed's top domains

Analyze Harbour BioMed engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

harbourbiomed.com00:00:21

See more with Sales Intelligence

Avg. pageviews on Harbour BioMed's top domains

See how Harbour BioMed keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

harbourbiomed.com1.74

See more with Sales Intelligence

Harbour BioMed top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Harbour BioMed

These are the website technologies, by industry, used by Harbour BioMed top domains

Mobile (3)

Meta Viewport

Advertising (1)

Baidu Ads

Conversion & Analytics (1)

Baidu Analytics

Email Services (1)

Microsoft Exchange Online

More Technologies

3

See all

News & Signals from Harbour BioMed

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsHarbour BioMed had earnings of $71.6M on Apr 1st '26.Adjusted net profit reached approximately US$71.6 million, marking seven consecutive profitable half-years and confirming that Harbour BioMed has officially entered a phase of "normalized profitability," further validating the sustainability and replicability of the business model underpinning this platform-based biopharmaceutical group.

NewsHarbour BioMed hired Youchen Chen as Executive Directors on Aug 27th '26.Harbour BioMed appoints Mr. Youchen Chen and Dr. Ian Y. Liu as Executive Directors.